hepatology
Looking at Disease Course and Mortality in MASH Patients
A new study of patients with MASH shows a six-year mortality rate of 10% in patients with compensated cirrhosis.
JANUARY 9, 2025
Echosens Launches Management Platform to Integrate With FibroScan Devices
A new cloud-based platform will offer result syncing and interpretation tools to integrate with the transient ...
NOVEMBER 20, 2024
FDA Declines to Grant Full Approval to Obeticholic Acid for PBC
The FDA has declined to grant full approval to obeticholic acid (Ocaliva, Intercept) for the treatment of adults ...
NOVEMBER 14, 2024
Simple Exercise Could Benefit Patients With End-Stage Liver Disease
A prehabilitation program for liver transplantation can help improve frailty metrics in patients with end-stage ...
NOVEMBER 5, 2024
Expert Picks From EASL 2024
Ashwani K. Singal, MD, MS, highlights four abstracts from EASL Congress 2024.
OCTOBER 30, 2024
New ACG Guideline on Managing Focal Liver Lesions
The American College of Gastroenterology recently released a new clinical guideline on focal liver lesions.
OCTOBER 17, 2024
Gastroenterology & Endoscopy News - Special Edition - Annual Supplement 2024
Digital Edition of Annual Supplement to Gastroenterology and Endoscopy News - 2024
OCTOBER 15, 2024
FDA Adds Warning of Serious Liver Injury to Menopause Drug
The FDA has added a warning of a rare occurrence of serious liver injury in patients taking the drug fezolinetant ...
OCTOBER 8, 2024
Vancomycin Linked to IBD Remission in Patients With Primary Sclerosing Cholangitis
Children with primary sclerosing cholangitis–associated inflammatory bowel disease may benefit from prolonged ...
SEPTEMBER 3, 2024
Noninvasive Tools Can Predict Liver-Related Events
A combination of a liver stiffness measurement and clinical parameters may allow prediction of liver-related ...
AUGUST 26, 2024
FDA Approves Seladelpar for Primary Biliary Cholangitis
The FDA has granted accelerated approval to seladelpar (Livdelzi, Gilead) in combination with ursodeoxycholic acid ...
AUGUST 21, 2024
